Johnson & Johnson (JNJ) reported $22.52 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 5.3%. EPS of $2.04 for the same period compares to $2.29 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $22.51 billion, representing a surprise of +0.06%. The company delivered an EPS surprise of +2.00%, with the consensus EPS estimate being $2.00.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Johnson & Johnson performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: